Metastatic Colorectal Cancer Clinical Trials in Poitiers
7 recruitingPoitiers, France
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Amgen450 enrolled284 locationsNCT06252649
Recruiting
Phase 2
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Metastatic Colorectal Cancer
AstraZeneca120 enrolled76 locationsNCT06792695
Recruiting
Phase 2
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
Metastatic Colorectal CancerMetastatic Gastroesophageal AdenocarcinomaDPD Deficiency
UNICANCER73 enrolled21 locationsNCT06245356
Recruiting
Not Applicable
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
Metastatic Colorectal CancerBRAF V600E Mutation Positive
UNICANCER400 enrolled45 locationsNCT05639413
Recruiting
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Metastatic Colorectal CancerCirculating Tumor DNA
GERCOR - Multidisciplinary Oncology Cooperative Group232 enrolled16 locationsNCT05787197
Recruiting
Phase 2
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group30 enrolled9 locationsNCT05310643
Recruiting
Not Applicable
TARGETed Therapy Drug MONITOring in DIGestive Oncology
Hepatocellular CarcinomaMetastatic Colorectal CancerNeuroendocrine Tumors+2 more
UNICANCER330 enrolled29 locationsNCT05443087